ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
FMC Corp. has agreed to sell its peroxygens business to One Equity Partners, the private investment arm of JPMorgan Chase, in a transaction the two firms value at about $200 million. FMC announced in April that it would divest the business as part of a corporate reorganization. The investment firm Jefferies estimated at the time that the business could be worth as much as $800 million. It has about $350 million in annual sales of hydrogen peroxide and persulfate chemicals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter